ARTICLES BY RAJENDRAN (RAJ) ARUNAGIRI
-
![Container ship-GettyImages-1404531423]( "3 Action Items For The US Bio/Pharma Industry To Mitigate Supply Vulnerabilities")
3 Action Items For The US Bio/Pharma Industry To Mitigate Supply Vulnerabilities6/12/2023The United States’ reliance on foreign manufacturers of API has been a known fact for several years. We can mitigate our supply vulnerabilities, but bio/pharma companies and the FDA both have roles to fill in this need.
Rajendran (Raj) Arunagiri
Rajendran (Raj) Arunagiri has been in the pharma industry for a decade and has successfully developed and launched a new excipient. He is a co-author of technical articles and is an invited speaker at conferences focused on excipients and drug delivery. He specializes in the area of poorly soluble APIs and modified release. Arunagiri welcomes you to reach out to him for questions, comments, and collaboration ideas at raj.gceb@gmail.com.
This website uses cookies to ensure you get the best experience on our website. Learn more